Quantcast

Cadence Pharmaceuticals’ CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011

March 2, 2011

SAN DIEGO, March 2, 2011 /PRNewswire/ — Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company’s President and CEO Ted Schroeder will present the company’s corporate overview on Wednesday, March 9, 2011 at 8:00am Eastern Time (5:00am Pacific Time) during the Cowen and Company 31st Annual Health Care Conference at the Boston Marriott Copley Place Hotel in Boston.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals’ website at www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 90 days.

About Cadence Pharmaceuticals

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company committed to in-licensing, developing and commercializing proprietary product candidates to improve the lives of hospitalized patients. For more information about Cadence, please visit www.cadencepharm.com


    Contacts:   William R. LaRue
                SVP, CFO
                Cadence Pharmaceuticals, Inc.
                858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.


Source: newswire



comments powered by Disqus